Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Tracheal Diseases 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Mesothelioma 1Lung Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Adenoid Cystic 1Breast Neoplasms 1Advanced or Metastatic Solid Tumors 1

Interventions

Pemetrexed 4Cisplatin 4pembrolizumab 3Nivolumab 3Interleukin-2 3Carboplatin 3atezolizumab 2aldesleukin 2Pharmaceutical Preparations 2Ipilimumab 2olaparib 1lenvatinib 1fludarabine 1enzalutamide 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Surgery, Computer-Assisted 1Proton Therapy 1Platinum 1Paclitaxel 1Injections 1Influenza Vaccines 1Indocyanine Green 1In Situ Hybridization, Fluorescence 1Cyclophosphamide 1Combined Modality Therapy 1Cerebral Decortication 1Brentuximab Vedotin 1Blood Component Removal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Mesothelioma, Malignant × Combined Modality Therapy × Clear all
NCT06251310 2026-05-08

SW-682 in Advanced Solid Tumors

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Phase 1 Recruiting
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡